CA Patent

CA2339188A1 — Isoxazolo¬4,5-d|pyrimidines as crf antagonists

Assigned to Bristol Myers Squibb Pharma Co · Expires 2000-03-02 · 26y expired

What this patent protects

The present invention describes novel isoxazolo[1,5-a]pyrimidines of formula (I), wherein R is an aromatic or heteroaromatic ring, or pharmaceutically acceptable salt form thereof, which are useful as CRF antagonists.

USPTO Abstract

The present invention describes novel isoxazolo[1,5-a]pyrimidines of formula (I), wherein R is an aromatic or heteroaromatic ring, or pharmaceutically acceptable salt form thereof, which are useful as CRF antagonists.

Drugs covered by this patent

Patent Metadata

Patent number
CA2339188A1
Jurisdiction
CA
Classification
—
Expires
2000-03-02
Drug substance claim
No
Drug product claim
No
Assignee
Bristol Myers Squibb Pharma Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.